1
|
Hosokawa M, Ichihashi Y, Sato Y, Shibata N, Nagasaki K, Ikegawa K, Hasegawa Y, Hamajima T, Nagamatsu F, Suzuki S, Numakura C, Amano N, Sasaki G, Nagahara K, Soneda S, Ariyasu D, Maeda M, Kamasaki H, Aso K, Hasegawa T, Ishii T. Incidence and Risk Factors for Adrenal Crisis in Pediatric-onset Adrenal Insufficiency: A Prospective Study. J Clin Endocrinol Metab 2023:dgad753. [PMID: 38128002 DOI: 10.1210/clinem/dgad753] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/03/2023] [Revised: 12/06/2023] [Accepted: 12/19/2023] [Indexed: 12/23/2023]
Abstract
PURPOSE To determine the incidence and risk factors for adrenal crisis (AC) in patients with pediatric-onset adrenal insufficiency (AI). MATERIALS AND METHODS This multicenter, prospective cohort study conducted in Japan enrolled patients diagnosed with AI at ≤ 15 years of age. The incidence of AC was calculated as events per person-year (PY), and risk factors for AC were assessed using Poisson regression multivariable analysis. RESULTS The study population comprised 349 patients (164 male, 185 female) with a total follow-up of 961 PY. The median age at enrollment was 14.3 years (interquartile range [IQR] 8.5-21.2 years), and the median follow-up was 2.8 years (IQR 2.2-3.3 years). Of these patients, 213 (61%) had primary AI and 136 (39%) had secondary AI. Forty-one AC events occurred in 31 patients during the study period. The calculated incidence of AC was 4.27 per 100 PY (95% confidence interval [CI] of 3.15-5.75). Poisson regression analysis identified younger age at enrollment (relative risk [RR] 0.93 [95% CI 0.89-0.97]) and increased number of infections (RR 1.17 [95% CI 1.07-1.27]) as significant risk factors. Female sex (RR 0.99 [95% CI 0.53-1.86]), primary AI (RR 0.65 [95 % CI 0.30-1.41]), or equivalent dosage of hydrocortisone per square meter of body area (RR 1.02 [95% CI 0.96-1.08]) was not a significant risk factor. CONCLUSION A substantial proportion of patients with pediatric-onset AI experience AC. Younger age and an increased number of infections are independent risk factors for developing AC in these patients.
Collapse
Affiliation(s)
- Mayumi Hosokawa
- Japanese Multicenter Study for Adrenal Crisis (JMSAC)
- Dept. of Pediatr., Keio Univ. Sch. of Med
- Dept. of Pediatr., Saitama City Hosp
| | - Yosuke Ichihashi
- Japanese Multicenter Study for Adrenal Crisis (JMSAC)
- Dept. of Pediatr., Keio Univ. Sch. of Med
| | - Yasunori Sato
- Dept. of Preventive Medicine and Public Health, Keio Univ. Sch. of Med
| | - Nao Shibata
- Japanese Multicenter Study for Adrenal Crisis (JMSAC)
- Dept. of Pediatr., Niigata Univ. Medical and Dental Hosp
| | - Keisuke Nagasaki
- Japanese Multicenter Study for Adrenal Crisis (JMSAC)
- Dept. of Pediatr., Niigata Univ. Medical and Dental Hosp
| | - Kento Ikegawa
- Japanese Multicenter Study for Adrenal Crisis (JMSAC)
- Dept. of Endocrinology and Metabolism, Tokyo Metropolitan Children's Medical Center
| | - Yukihiro Hasegawa
- Japanese Multicenter Study for Adrenal Crisis (JMSAC)
- Dept. of Endocrinology and Metabolism, Tokyo Metropolitan Children's Medical Center
| | - Takashi Hamajima
- Japanese Multicenter Study for Adrenal Crisis (JMSAC)
- Dept. of Endocrinology and Metabolism, Aichi Children's Health and Medical Center
| | - Fusa Nagamatsu
- Japanese Multicenter Study for Adrenal Crisis (JMSAC)
- Dept. of Pediatr., Kumamoto Univ. Sch. of Med
| | - Shigeru Suzuki
- Japanese Multicenter Study for Adrenal Crisis (JMSAC)
- Dept. of Pediatr., Asahikawa Medical Univ
| | - Chikahiko Numakura
- Japanese Multicenter Study for Adrenal Crisis (JMSAC)
- Dept. of Pediatr., Yamagata Univ. Faculty of Med
| | - Naoko Amano
- Japanese Multicenter Study for Adrenal Crisis (JMSAC)
- Dept. of Pediatr., Saitama City Hosp
| | - Goro Sasaki
- Japanese Multicenter Study for Adrenal Crisis (JMSAC)
- Dept. of Pediatr., Tokyo Dental College Ichikawa General Hosp
| | - Keiko Nagahara
- Japanese Multicenter Study for Adrenal Crisis (JMSAC)
- Dept. of Pediatr., Showa Univ, Sch. of Med
| | - Shun Soneda
- Japanese Multicenter Study for Adrenal Crisis (JMSAC)
- Dept. of Pediatr., St. Marianna Univ., Sch. of Med
| | - Daisuke Ariyasu
- Japanese Multicenter Study for Adrenal Crisis (JMSAC)
- Dept. of Pediatr., Kawasaki Municipal Hosp
| | - Miwako Maeda
- Japanese Multicenter Study for Adrenal Crisis (JMSAC)
- Dept. of Pediatr., Oita Univ. Faculty of Med
| | - Hotaka Kamasaki
- Japanese Multicenter Study for Adrenal Crisis (JMSAC)
- Dept. of Pediatr., Sapporo Medical Univ
| | - Keiko Aso
- Japanese Multicenter Study for Adrenal Crisis (JMSAC)
- Dept of Pediatr., Toho Univ. Omori Medical Center
| | - Tomonobu Hasegawa
- Japanese Multicenter Study for Adrenal Crisis (JMSAC)
- Dept. of Pediatr., Keio Univ. Sch. of Med
| | - Tomohiro Ishii
- Japanese Multicenter Study for Adrenal Crisis (JMSAC)
- Dept. of Pediatr., Keio Univ. Sch. of Med
| |
Collapse
|
2
|
Ariyasu D, Nagamatsu F, Aso K, Akiba K, Hasegawa Y. Longitudinal clinical course in patients with 5α-reductase type 2 deficiency treated with testosterone and dihydrotestosterone during infancy and puberty. Endocr J 2023; 70:59-67. [PMID: 36216557 DOI: 10.1507/endocrj.ej22-0112] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/01/2023] Open
Abstract
5α-reductase type 2 (5αRD2) deficiency is a 46,XY disorder of sex development caused by impaired conversion of testosterone (T) to dihydrotestosterone (DHT). Penile enlargement therapy is important for male patients with 46,XY 5αRD2 deficiency who have undermasculinized external genitalia, such as severe micropenis. High-dose T and percutaneous DHT replacement are reportedly efficacious for penile enlargement in patients with this disorder. We presented herein the longitudinal course of four patients with 46,XY 5αRD2 deficiency who received T and DHT. T replacement therapy during infancy increased the stretched penile length (SPL) in three of the patients but was ineffective in one patient. DHT was administered to the three patients after T replacement therapy and further increased the SPL. During and after puberty, two patients asked for and received T replacement therapy, which contributed to increasing their SPL. A semen test in one patient with T replacement therapy at age 27 years revealed cryptozoospermia despite normal testicular volume. The clinical course of our patients during infancy indicated that DHT therapy may be preferrable to T replacement therapy for penile enlargement in patients with 5αRD2 deficiency. During and after puberty, T replacement therapy promoted penile enlargement possibly because of increased conversion of T to DHT via increased 5α-reductase type 1 activity even in patients in whom it was ineffective during infancy. In conclusion, DHT is effective for penile enlargement during infancy in patients with 5αRD2 deficiency while T replacement therapy is a viable option during puberty.
Collapse
Affiliation(s)
- Daisuke Ariyasu
- Department of Pediatrics, Kawasaki Municipal Hospital, Kanagawa 210-0013, Japan
- Division of Endocrinology and Metabolism, Tokyo Metropolitan Children's Medical Center, Tokyo 183-8561, Japan
| | - Fusa Nagamatsu
- Division of Endocrinology and Metabolism, Tokyo Metropolitan Children's Medical Center, Tokyo 183-8561, Japan
- Department of Pediatrics, Kumamoto University Hospital, Kumamoto 860-8556, Japan
| | - Keiko Aso
- Department of Pediatrics, Toho University Omori Medical Center, Tokyo 143-8541, Japan
| | - Kazuhisa Akiba
- Division of Endocrinology and Metabolism, Tokyo Metropolitan Children's Medical Center, Tokyo 183-8561, Japan
- Department of Molecular Endocrinology, National Research Institute for Child Health and Development, Tokyo 157-8535, Japan
| | - Yukihiro Hasegawa
- Division of Endocrinology and Metabolism, Tokyo Metropolitan Children's Medical Center, Tokyo 183-8561, Japan
| |
Collapse
|
3
|
Ariyasu D, Kubo E, Higa D, Shibata S, Takaoka Y, Sugimoto M, Imaizumi K, Hasegawa T, Araki K. Decreased Activity of the Ghrhr and Gh Promoters Causes Dominantly Inherited GH Deficiency in Humanized GH1 Mouse Models. Endocrinology 2019; 160:2673-2691. [PMID: 31436800 DOI: 10.1210/en.2019-00306] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/23/2019] [Accepted: 08/15/2019] [Indexed: 02/06/2023]
Abstract
Isolated growth hormone deficiency type II (IGHD2) is mainly caused by heterozygous splice-site mutations in intron 3 of the GH1 gene. A dominant-negative effect of the mutant GH lacking exon 3 on wild-type GH secretion has been proposed; however, the molecular mechanisms involved are elusive. To uncover the molecular systems underlying GH deficiency in IGHD2, we established IGHD2 model mice, which carry both wild-type and mutant copies of the human GH1 gene, replacing each of the endogenous mouse Gh loci. Our IGHD2 model mice exhibited growth retardation along with intact cellular architecture and mildly activated endoplasmic reticulum stress in the pituitary gland, caused by decreased GH-releasing hormone receptor (Ghrhr) and Gh gene promoter activities. Decreased Ghrhr and Gh promoter activities were likely caused by reduced levels of nuclear CREB3L2, which was demonstrated to stimulate Ghrhr and Gh promoter activity. To our knowledge, this is the first in vivo study to reveal a novel molecular mechanism of GH deficiency in IGHD2, representing a new paradigm that differs from widely accepted models.
Collapse
Affiliation(s)
- Daisuke Ariyasu
- Division of Developmental Genetics, Institute of Resource Development and Analysis, Kumamoto University, Kumamoto, Japan
- Graduate School of Medicine, Keio University, Tokyo, Japan
| | - Emika Kubo
- Division of Developmental Genetics, Institute of Resource Development and Analysis, Kumamoto University, Kumamoto, Japan
| | - Daisuke Higa
- Division of Developmental Genetics, Institute of Resource Development and Analysis, Kumamoto University, Kumamoto, Japan
| | - Shinsuke Shibata
- Electron Microscope Laboratory, Keio University School of Medicine, Tokyo, Japan
| | - Yutaka Takaoka
- Division of Medical Informatics and Bioinformatics, Kobe University Hospital, Hyogo, Japan
| | - Michihiko Sugimoto
- Division of Developmental Genetics, Institute of Resource Development and Analysis, Kumamoto University, Kumamoto, Japan
| | - Kazunori Imaizumi
- Department of Biochemistry, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
| | | | - Kimi Araki
- Division of Developmental Genetics, Institute of Resource Development and Analysis, Kumamoto University, Kumamoto, Japan
- Center for Metabolic Regulation of Healthy Aging, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan
| |
Collapse
|
4
|
Hasegawa Y, Ariyasu D, Izawa M, Igaki-Miyamoto J, Fukuma M, Hatano M, Yagi H, Goto M. Gradually increasing ethinyl estradiol for Turner syndrome may produce good final height but not ideal BMD. Endocr J 2017; 64:221-227. [PMID: 27916781 DOI: 10.1507/endocrj.ej16-0170] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/23/2022] Open
Abstract
Estrogen replacement therapy in Turner syndrome should theoretically mimic the physiology of healthy girls. The objective of this study was to describe final height and bone mineral density (BMD) in a group of 17 Turner syndrome patients (group E) who started their ethinyl estradiol therapy with an ultra-low dosage (1-5 ng/kg/day) from 9.8-13.7 years. The subjects in group E had been treated with GH 0.35 mg/kg/week since the average age of 7.4 years. The 30 subjects in group L, one of the historical groups, were given comparable doses of GH, and conjugated estrogen 0.3125 mg/week ∼0.3125 mg/day was initiated at 12.2-18.7 years. The subjects in group S, the other historical group, were 21 patients who experienced breast development and menarche spontaneously. Final height (height gain < 2 cm/year) in group E was 152.4 ± 3.4 cm and the standard deviation (SD) was 2.02 ± 0.62 for Turner syndrome. The final height in group L was 148.5 ± 3.0 cm with a SD of 1.30 ± 0.55, which was significantly different from the values for group E. The volumetric BMD of group S (0.290 ± 0.026 g/cm3) was significantly different from that of group L or E (0.262 or 0.262 g/cm3 as a mean, respectively). This is the first study of patients with Turner syndrome where estrogen was administered initially in an ultra-low dose and then increased gradually. Our estrogen therapy in group E produced good final height but not ideal BMD.
Collapse
Affiliation(s)
- Yukihiro Hasegawa
- Division of Endocrinology and Metabolism, Tokyo Metropolitan Children's Medical Center, Tokyo, Japan
| | | | | | | | | | | | | | | |
Collapse
|
5
|
Ariyasu D, Yoshida H, Hasegawa Y. Endoplasmic Reticulum (ER) Stress and Endocrine Disorders. Int J Mol Sci 2017; 18:ijms18020382. [PMID: 28208663 PMCID: PMC5343917 DOI: 10.3390/ijms18020382] [Citation(s) in RCA: 70] [Impact Index Per Article: 10.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/22/2016] [Revised: 01/24/2017] [Accepted: 02/03/2017] [Indexed: 12/15/2022] Open
Abstract
The endoplasmic reticulum (ER) is the organelle where secretory and membrane proteins are synthesized and folded. Unfolded proteins that are retained within the ER can cause ER stress. Eukaryotic cells have a defense system called the “unfolded protein response” (UPR), which protects cells from ER stress. Cells undergo apoptosis when ER stress exceeds the capacity of the UPR, which has been revealed to cause human diseases. Although neurodegenerative diseases are well-known ER stress-related diseases, it has been discovered that endocrine diseases are also related to ER stress. In this review, we focus on ER stress-related human endocrine disorders. In addition to diabetes mellitus, which is well characterized, several relatively rare genetic disorders such as familial neurohypophyseal diabetes insipidus (FNDI), Wolfram syndrome, and isolated growth hormone deficiency type II (IGHD2) are discussed in this article.
Collapse
Affiliation(s)
- Daisuke Ariyasu
- Division of Developmental Genetics, Institute of Resource Development and Analysis, Kumamoto University, Kumamoto 860-0811, Japan.
| | - Hiderou Yoshida
- Department of Biochemistry and Molecular Biology, Graduate School of Life Science, University of Hyogo, Hyogo 678-1297, Japan.
| | - Yukihiro Hasegawa
- Division of Endocrinology and Metabolism, Tokyo Metropolitan Children's Medical Center, Tokyo 183-8561, Japan.
| |
Collapse
|
6
|
Nagahara K, Ariyasu D, Igaki J, Hasegawa Y, Hasegawa Y. A Japanese boy with fructose-1,6-bisphosphatase deficiency who had a novel <i>FBP1</i> mutation (p.Phe90Val). Clin Pediatr Endocrinol 2017; 26:275-278. [PMID: 29026278 PMCID: PMC5627230 DOI: 10.1297/cpe.26.275] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/21/2016] [Accepted: 04/26/2017] [Indexed: 11/13/2022] Open
Affiliation(s)
- Keiko Nagahara
- Department of Endocrinology and Metabolism, Tokyo Metropolitan Children’s Medical Center, Tokyo, Japan
- Department of Pediatrics, Showa University School of Medicine, Tokyo, Japan
| | - Daisuke Ariyasu
- Division of Developmental Genetics, Institute of Resource Development and Analysis, Kumamoto University, Kumamoto, Japan
| | - Junko Igaki
- Department of Endocrinology and Metabolism, Okinawa Prefectural Nanbu Medical Center & Children’s Medical Center, Okinawa, Japan
| | - Yuki Hasegawa
- Department of Pediatrics, Shimane University School of Medicine, Shimane, Japan
| | - Yukihiro Hasegawa
- Department of Endocrinology and Metabolism, Tokyo Metropolitan Children’s Medical Center, Tokyo, Japan
| |
Collapse
|
7
|
Takagi M, Takeda R, Yagi H, Ariyasu D, Fukuzawa R, Hasegawa T. A case of transient neonatal diabetes due to a novel mutation in ABCC8. Clin Pediatr Endocrinol 2016; 25:139-141. [PMID: 27780984 PMCID: PMC5069543 DOI: 10.1297/cpe.25.139] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/02/2016] [Accepted: 08/27/2016] [Indexed: 11/21/2022] Open
Affiliation(s)
- Masaki Takagi
- Department of Pediatrics, Keio University School of Medicine, Tokyo, Japan; Department of Pathology and Laboratory Medicine, Tokyo Metropolitan Children's Medical Center, Tokyo, Japan
| | - Ryojun Takeda
- Department of Medical Genetics, Tokyo Metropolitan Children's Medical Center, Tokyo, Japan
| | - Hiroko Yagi
- Department of Genetic Research, Tokyo Metropolitan Children's Medical Center, Tokyo, Japan
| | - Daisuke Ariyasu
- Division of Developmental Genetics, Institute of Resource Development and Analysis, Kumamoto University, Kumamoto, Japan
| | - Ryuji Fukuzawa
- Department of Pathology and Laboratory Medicine, Tokyo Metropolitan Children's Medical Center, Tokyo, Japan
| | - Tomonobu Hasegawa
- Department of Pediatrics, Keio University School of Medicine, Tokyo, Japan
| |
Collapse
|
8
|
Fukuma M, Ariyasu D, Hatano M, Yagi H, Hasegawa Y. Early-onset urological disorders due to Wolfram syndrome: A case of neonatal onset. Clin Pediatr Endocrinol 2016; 25:67-9. [PMID: 27212798 PMCID: PMC4860517 DOI: 10.1297/cpe.25.67] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/11/2015] [Accepted: 12/01/2015] [Indexed: 11/04/2022] Open
Affiliation(s)
- Mami Fukuma
- Division of Endocrinology and Metabolism, Tokyo Metropolitan Children's Medical Center, Tokyo, Japan
| | - Daisuke Ariyasu
- Division of Endocrinology and Metabolism, Tokyo Metropolitan Children's Medical Center, Tokyo, Japan
| | - Megumi Hatano
- Division of Endocrinology and Metabolism, Tokyo Metropolitan Children's Medical Center, Tokyo, Japan
| | - Hiroko Yagi
- Division of Endocrinology and Metabolism, Tokyo Metropolitan Children's Medical Center, Tokyo, Japan
| | - Yukihiro Hasegawa
- Division of Endocrinology and Metabolism, Tokyo Metropolitan Children's Medical Center, Tokyo, Japan
| |
Collapse
|
9
|
Miyai K, Ariyasu D, Numakura C, Yoneda K, Nakazato H, Hasegawa Y. Hypophosphatemic rickets developed after treatment with etidronate disodium in a patient with generalized arterial calcification in infancy. Bone Rep 2015; 3:57-60. [PMID: 28377967 PMCID: PMC5365274 DOI: 10.1016/j.bonr.2015.09.001] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/27/2015] [Revised: 08/31/2015] [Accepted: 09/02/2015] [Indexed: 12/02/2022] Open
Abstract
Ectonucleotide pyrophosphatase/phosphodiesterase 1 (ENPP1) was originally reported as a responsible gene for generalized arterial calcification in infancy (GACI). Though the prognosis of GACI patients is poor because of myocardial infarction and heart failure in relation to medial calcification of the coronary arteries, some patients rescued by bisphosphonate treatment have been reported. Recently, ENPP1 is also reported as responsible for autosomal recessive hypophosphatemic rickets type 2. We show here a boy with homozygous ENPP1 mutations diagnosed as having GACI in early infancy. After the diagnosis, he was treated with etidronate disodium (EHDP) in combination with antihypertensive drugs. The calcification of major arteries was diminished and disappeared by the age of eight months. He also showed mild hypophosphatemia (2.6–3.7 mg/dl) from the age of one year. After the treatment with EHDP for five years, he showed genu valgum with hypophosphatemia (2.6 mg/dl). He was diagnosed as having hypophosphatemic rickets at the age of seven years. The findings that hyper-mineralization of the arteries and hypo-mineralization of the bone observed in the same patient are noteworthy. ENPP1 could be regarded as a controller of the calcification of the whole body at least in part. A boy with homozygous ENPP1 mutation suffered GACI and subsequent hypophosphatemic rickets. ENPP1 mutation caused both hyper-mineralization in the arteries and hypo-mineralization in the bone in the same patient. ENPP1 could be regarded as a mineralization controller of the body.
Collapse
Affiliation(s)
- Kentaro Miyai
- Division of Endocrinology and Metabolism, Tokyo Metropolitan Children's Medical Center, 2-8-29 Musashidai, Fuchu, Tokyo 183-8561, Japan
- Corresponding author at: Tokyo Metropolitan Children's Medical Center, 2-8-29 Musashidai, Fuchu, Tokyo 183-8561, Japan.Tokyo Metropolitan Children's Medical Center2-8-29 MusashidaiFuchuTokyo183-8561Japan
| | - Daisuke Ariyasu
- Division of Developmental Genetics, Institute of Resource Development and Analysis, Kumamoto University, 2-2-1 Honjo, Chuo-ku, Kumamoto 860-0811, Japan
| | - Chikahiko Numakura
- Department of Pediatrics, Yamagata University School of Medicine, 2-2-2 Iida-nishi, Yamagata 990-9585, Japan
| | - Kaori Yoneda
- Department of Pediatrics, Kumamoto University, 1-1-1 Honjo, Chuo-ku, Kumamoto 860-8556, Japan
| | - Hitoshi Nakazato
- Department of Pediatrics, Kumamoto University, 1-1-1 Honjo, Chuo-ku, Kumamoto 860-8556, Japan
| | - Yukihiro Hasegawa
- Division of Endocrinology and Metabolism, Tokyo Metropolitan Children's Medical Center, 2-8-29 Musashidai, Fuchu, Tokyo 183-8561, Japan
| |
Collapse
|
10
|
Ariyasu D, Yoshida H, Yamada M, Hasegawa Y. Endoplasmic reticulum stress and apoptosis contribute to the pathogenesis of dominantly inherited isolated GH deficiency due to GH1 gene splice site mutations. Endocrinology 2013; 154:3228-39. [PMID: 23736291 DOI: 10.1210/en.2013-1249] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
Abstract
Dominantly inherited isolated GH deficiency is mainly caused by a heterozygous donor site mutation of intron 3 in the GH1 gene. An exon 3 deletion in GH (del32-71 GH) is produced from a mutant allele, whereas wild-type GH is produced from the other allele. Several studies have demonstrated a dominant negative effect of del32-71 GH on wild-type GH secretion, but the precise molecular mechanisms remain unclear. We hypothesized that unfolded del32-71 GH accumulates in the endoplasmic reticulum (ER) and causes ER stress and apoptosis in somatotrophs, promoting GH deficiency. To evaluate del32-71 GH-mediated ER stress, we established GH4C1 cell lines with doxycycline (dox)-controlled del32-71 GH expression. In 20 of 23 dox-controlled cell lines, the concentration of wild-type GH in the culture medium significantly decreased with del32-71 GH induction, demonstrating the dominant negative effect of this mutant. Cell viability, mRNA abundance of ER stress-response genes, caspase activation, and DNA fragmentation were evaluated in 5 dox-controlled cell lines selected as cellular models. In 4 of the 5 cell lines, del32-71 GH induction decreased cell viability, increased expression of 3 major ER stress response pathways (PRKR-like endoplasmic reticulum kinase [PERK], activating transcription factor-6 [ATF6], and inositol requirement 1 [IRE1]), and induced caspase-3 and caspase-7 activation. In 1 of the 4 cell lines, DNA fragmentation was demonstrated. Finally, overexpression of XBP1(S), a nuclear transcription factor downstream of IRE1, completely reversed the observed caspase activation. These data suggested that del32-71 GH-mediated ER stress and apoptosis contributed to the decrease in wild-type GH secretion observed in GH deficiency due to the GH1 gene slice-site mutations.
Collapse
Affiliation(s)
- Daisuke Ariyasu
- Department of Endocrinology and Metabolism, Tokyo Metropolitan Children’s Medical Center, Tokyo 183–8561, Japan
| | | | | | | |
Collapse
|
11
|
Takenouchi T, Okuno H, Kosaki R, Ariyasu D, Torii C, Momoshima S, Harada N, Yoshihashi H, Takahashi T, Awazu M, Kosaki K. Microduplication of Xq24 and Hartsfield syndrome with holoprosencephaly, ectrodactyly, and clefting. Am J Med Genet A 2012; 158A:2537-41. [PMID: 22887648 DOI: 10.1002/ajmg.a.35465] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/13/2012] [Accepted: 04/13/2012] [Indexed: 12/22/2022]
Abstract
The combination of holoprosencephaly and ectrodactyly, also known as Hartsfield syndrome, represents a unique genetic entity. An X-linked recessive mode of transmission has been suggested for this condition based on the observation that male patients have preferentially been affected. Thus far, no candidate genes have been suggested on the X chromosome. We report a male patient with a full-blown Hartsfield syndrome phenotype who had microduplication at Xq24 involving four genes. He presented with bilateral ectrodactyly of the hands (both hands had four fingers with a deep gap between the 2nd and 3rd digits), cleft lip and palate, and a depressed nasal bridge. Magnetic resonance imaging of the brain revealed lobar holoprosencephaly. His G-banded karyotype was normal. Array comparative genomic hybridization (CGH) using the Agilent 244K Whole Human Genome CGH array revealed a microduplication at Xq24 of 210 kb. Parental testing revealed that the deletion was derived from the asymptomatic mother. Of the genes on the duplicated interval, the duplications of SLC25A43 and SLC25A5 appeared to be the most likely to explain the patient's phenotype. From a clinical standpoint, it is important to point out that the propositus, who performs relatively well with holoprosencephaly and has a developmental quotient around 70, has survived multiple life-threatening episodes of hypernatremia. Awareness of the risk of hypernatremia is of great importance for the anticipatory management of patients with ectrodactyly and an oral cleft, even in the absence of overt hypotelorism.
Collapse
Affiliation(s)
- Toshiki Takenouchi
- Department of Pediatrics, Keio University School of Medicine, Tokyo, Japan
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
12
|
Terano C, Miura M, Fukuzawa R, Saito Y, Arai H, Sasaki M, Ariyasu D, Hasegawa Y. Three children with plastic bronchitis associated with 2009 H1N1 influenza virus infection. Pediatr Infect Dis J 2011; 30:80-2. [PMID: 20686435 DOI: 10.1097/inf.0b013e3181f10fff] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
Abstract
We report the cases of 3 children with plastic bronchitis associated with 2009 H1N1 influenza virus infection. These 3 children shared common clinical and radiologic features: rapid and progressive respiratory distress with whole lung atelectasis on chest radiograph. In children with severe respiratory symptoms accompanied by H1N1 influenza, plastic bronchitis should be considered.
Collapse
Affiliation(s)
- Chikako Terano
- Department of General Medicine, Tokyo Metropolitan Children's Medical Center, Fuchu, Tokyo, Japan
| | | | | | | | | | | | | | | |
Collapse
|
13
|
Igaki JM, Yamada M, Yamazaki Y, Koto S, Izawa M, Ariyasu D, Suzuki E, Hasegawa H, Hasegawa Y. High iFGF23 level despite hypophosphatemia is one of the clinical indicators to make diagnosis of XLH. Endocr J 2011; 58:647-55. [PMID: 21597229 DOI: 10.1507/endocrj.k10e-257] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/23/2022] Open
Abstract
X-linked hypophosphatemic rickets (XLH) is caused by inactivating mutations in the phosphate-regulating gene with homologies to endopeptidases on the X chromosome (PHEX) gene. Deletion of Phex leads to increased serum fibroblast growth factor23 (FGF23) levels in mouse. The aim is to assure the clinical usefulness of FGF23 determination in the diagnosis of XLH. Participants were 21 patients with XLH having abnormalities in PHEX from 13 kindred (PtPHEX: 1 to 42 years old; 10 males, 11 females) and 55 healthy controls (1 month to 18 years old; 27 males, 28 females). Temporal changes in FGF23 were determined by a single oral phosphate administration in PtPHEX and an ad lib diet in controls. Reference ranges of intact FGF23 (iFGF23) for children were determined. iFGF23 level which distinguish between controls and PtPHEX were validated. Correlations between iFGF23 and the severity of XLH (gender, age of onset, bone deformity, The ratio of maximum rate of renal tubular reabsorption of phosphate to glomerular filtration rate (TmPO(4)/GFR), inorganic phosphate (IP), Alkaline Phosphatase (ALP), therapeutic dose) were investigated. Increasing tendency after phosphate administration and no general tendency after breakfast in iFGF23 were observed. Reference range (5(th) and 95(th) percentiles) of iFGF23 for children (12.9 and 51.2 pg/mL) was similar to that for adults. iFGF23 were above the reference range in 19 of 21 PtPHEX (40 to 4710 pg/mL). iFGF23 did not correlate with any index of severity of XLH. Relatively high iFGF23 despite hypophosphatemia is one of the clinical indicators to diagnose XLH.
Collapse
Affiliation(s)
- Junko Miyamoto Igaki
- Division of Endocrinology and Metabolism, Tokyo Metropolitan Children's Hospital, Japan.
| | | | | | | | | | | | | | | | | |
Collapse
|
14
|
Aso K, Koto S, Higuchi A, Ariyasu D, Izawa M, Miyamoto Igaki J, Hasegawa Y. Serum FSH level below 10 mIU/mL at twelve years old is an index of spontaneous and cyclical menstruation in Turner syndrome. Endocr J 2010; 57:909-13. [PMID: 20798475 DOI: 10.1507/endocrj.k10e-092] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/23/2022] Open
Abstract
The gonadal function of patients with Turner syndrome (TS) is variable. Individuals with mosaicism characterized by 45,X/46,XX or 45,X/47,XXX are more likely to experience spontaneous menarche compared with other karyotypes. Prepubertal gonadotropins of TS patients with spontaneous menarche are reportedly normal or significantly lower than those of patients with induced menarche. The present study investigated an index of spontaneous and cyclical menstruation at 10-12 years old in TS. Subjects comprised 50 patients with TS, divided into three groups: Group A (n=7), with spontaneous menarche before 16 years old and regular menstruation for at least 1 year and 6 months; Group B (n=6), with irregular menstruation since menarche leading to secondary amenorrhea despite spontaneous menarche before 16 years old; and Group C (n=37), without spontaneous breast budding before 14 years old or without spontaneous menarche before 16 years old. Karyotype, LH and FSH concentrations at 10 and 12 years old were analyzed retrospectively. Spontaneous and cyclical menstruation was more frequently observed in TS with mosaicism characterized by 45,X/46,XX or 45,X/47,XXX than in TS with other karyotypes, as previously described. Spontaneous and cyclical menstruation in TS was observed when serum FSH level was <10 mIU/mL at 12 years old, suggesting this FSH level as an index of spontaneous and cyclical menstruation in TS.
Collapse
Affiliation(s)
- Keiko Aso
- Endocrinology and Metabolism Division, Tokyo Metropolitan Children's Medical Center, Tokyo, Japan.
| | | | | | | | | | | | | |
Collapse
|
15
|
Suzuki E, Yamada M, Ariyasu D, Izawa M, Miyamoto J, Koto S, Hasegawa Y. Patients with Hypophosphatemic Osteomalacia Need Continuous Treatment during Adulthood. Clin Pediatr Endocrinol 2009; 18:29-33. [PMID: 24790377 PMCID: PMC4004881 DOI: 10.1297/cpe.18.29] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/11/2008] [Accepted: 11/13/2008] [Indexed: 11/15/2022] Open
Abstract
The treatment for hypophosphatemic rickets in children includes phosphate and
vitamin D preparations. In children, this regimen significantly improves symptoms, while a
treatment for adult patients has not been established. We therefore investigated the
clinical courses of 15 adult patients who discontinued therapy when final height was
achieved in order to assess the necessity of treatment in adulthood. Thirteen patients
developed symptomatic complications, including bone fractures. Among the 13, the 10
patients who restarted therapy all showed clinical improvement, and no side effects of
treatment were observed. This study shows that there are some patients with
hypophosphatemic osteomalacia who need continuous treatment during adulthood.
Collapse
Affiliation(s)
- Eri Suzuki
- Department of Endocrinology and Metabolism, Tokyo Metropolitan Kiyose Children's Hospital, Tokyo, Japan
| | - Makoto Yamada
- Department of Endocrinology and Metabolism, Tokyo Metropolitan Kiyose Children's Hospital, Tokyo, Japan
| | - Daisuke Ariyasu
- Department of Endocrinology and Metabolism, Tokyo Metropolitan Kiyose Children's Hospital, Tokyo, Japan
| | - Masako Izawa
- Department of Endocrinology and Metabolism, Tokyo Metropolitan Kiyose Children's Hospital, Tokyo, Japan
| | - Junko Miyamoto
- Department of Endocrinology and Metabolism, Tokyo Metropolitan Kiyose Children's Hospital, Tokyo, Japan
| | - Shinobu Koto
- Department of Endocrinology and Metabolism, Tokyo Metropolitan Kiyose Children's Hospital, Tokyo, Japan
| | - Yukihiro Hasegawa
- Department of Endocrinology and Metabolism, Tokyo Metropolitan Kiyose Children's Hospital, Tokyo, Japan
| |
Collapse
|
16
|
Izawa M, Aso K, Higuchi A, Ariyasu D, Hasegawa Y. The Range of 2.2-3.3 mg/gCr of Pregnanetriol in the First Morning Urine Sample as an Index of Optimal Control in CYP21 Deficiency. Clin Pediatr Endocrinol 2008; 17:75-80. [PMID: 24790367 PMCID: PMC4004858 DOI: 10.1297/cpe.17.75] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/25/2008] [Accepted: 05/26/2008] [Indexed: 11/25/2022] Open
Abstract
Auxological data are the gold standard indexes of the therapeutic conditions in patients
with CYP21 deficiency over long-term periods, whereas urinary pregnanetriol (PT) for 24 h
has been used as an index for short-term periods. We previously reported that the range of
1.2–2.1 mg/m2/day of PT for 24 h (24-h PT) could be used as an index of optimal
control in patients with CYP21 deficiency. The purpose of this study was to analyze the
range of PT in the first morning urine samples (morning PT) as an index of optimal control
in patients with CYP21 deficiency. First, the therapeutic periods of 15 participants (aged
2 yr and 5 mo to 17 yr and 4 mo) were classified into excessive, good or poor control
periods using auxological data and Cushing-like symptoms, and 24-h PT levels were analyzed
in each period, retrospectively. The 95% confidence intervals for the means of 24-h PT
levels in the excessive, good and poor control periods were 0.24–2.24 (n=25), 2.88–4.92
(n=114) and 13.26–21.28 (n=72) mg/gCr, respectively. Subsequently, 24-h PT and morning PT
levels collected on the same day were analyzed for 14 participants (aged 9 mo to 29 yr and
8 mo). There was a significant correlation between the above two PT levels (n=25,
p<0.0001). When the 24-h PT range of the good control period, 2.88–4.92 mg/gCr, was
adjusted by the correlation, the ideal morning PT range became 2.15–3.34 mg/gCr. In
conclusion, a morning PT in the range of 2.2–3.3 mg/gCr can be used as an index of optimal
control in patients with CYP21 deficiency.
Collapse
Affiliation(s)
- Masako Izawa
- Division of Endocrinology and Metabolism, Tokyo Metropolitan Kiyose Children's Hospital, Tokyo, Japan
| | - Keiko Aso
- Division of Endocrinology and Metabolism, Tokyo Metropolitan Kiyose Children's Hospital, Tokyo, Japan
| | - Asako Higuchi
- Division of Endocrinology and Metabolism, Tokyo Metropolitan Kiyose Children's Hospital, Tokyo, Japan
| | - Daisuke Ariyasu
- Division of Endocrinology and Metabolism, Tokyo Metropolitan Kiyose Children's Hospital, Tokyo, Japan
| | - Yukihiro Hasegawa
- Division of Endocrinology and Metabolism, Tokyo Metropolitan Kiyose Children's Hospital, Tokyo, Japan
| |
Collapse
|
17
|
Kanemoto K, Ishikura K, Ariyasu D, Hamasaki Y, Hataya H, Hasegawa Y, Ikeda M. WT1 intron 9 splice acceptor site mutation in a 46,XY male with focal segmental glomerulosclerosis. Pediatr Nephrol 2007; 22:454-8. [PMID: 17061122 DOI: 10.1007/s00467-006-0333-x] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/17/2006] [Revised: 09/12/2006] [Accepted: 09/14/2006] [Indexed: 10/24/2022]
Abstract
The Wilms' tumor suppressor gene (WT1) plays crucial roles in urogenital and gonadal development. Germline mutations of WT1 have been reported in patients with Denys-Drash syndrome (DDS) and Frasier syndrome (FS). Based on clinical overlaps reported to date, it has been suggested that these two syndromes should be considered as part of a spectrum of diseases caused by WT1 gene mutations, rather than as separate diseases. We report a new mutation in an intron 9 splice acceptor site (IVS -1G-->) in a Japanese 46,XY male patient with focal segmental glomerulosclerosis (FSGS) and bilateral cryptorchism. The clinical phenotype of this patient resembled FS without male pseudohermaphroditism. Interestingly, although the patient's right kidney was diagnosed with FSGS, his left kidney showed severe hypoplasia. There are no previous case reports of FSGS and renal hypoplasia in the same individual with a WT1 mutation. The findings for this case further suggest that the renal phenotype has various manifestations and is not always decided by the type of WT1 mutation. The possibility that the position of the WT1 mutation may influence the course of the nephropathy should be evaluated in a larger patient cohort.
Collapse
Affiliation(s)
- Katsuyoshi Kanemoto
- Department of Nephrology, Tokyo Metropolitan Kiyose Children's Hospital, 1-3-1 Umezono, Kiyose, Tokyo, 204-8567, Japan.
| | | | | | | | | | | | | |
Collapse
|
18
|
Izawa M, Aso K, Higuchi A, Ariyasu D, Hasegawa Y. Pregnanetriol in the Range of 1.2-2.1 mg/m(2)/day as an Index of Optimal Control in CYP21A2 Deficiency. Clin Pediatr Endocrinol 2007; 16:45-52. [PMID: 24790344 PMCID: PMC4004871 DOI: 10.1297/cpe.16.45] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/29/2006] [Accepted: 01/18/2007] [Indexed: 11/30/2022] Open
Abstract
Auxological data is the gold standard index of the therapeutic condition in CYP21A2
deficiency over a long-range period, whereas urinary pregnanetriol for 24 h (PT) is
variable for a shorter-range period. Ideal PT levels in comparison with auxological data
have not been reported. The main purpose of this study was to analyze ideal PT values as
an index of optimal control for CYP21A2 deficiency. First, inter-daily fluctuation of PT
was analyzed in one participant. PT levels were distributed over a wide range of 0.44–14.7
mg/day (n=42) in this participant, suggesting that the therapeutic condition should be
judged by multiple PT samples. Second, the therapeutic periods of 15 participants with
CYP21A2 deficiency were classified using auxological data and Cushing-like symptoms, and
the PT levels were analyzed in each period retrospectively. The 95% confidence intervals
for the means of the PT levels in the excessive, good and poor control periods were
0.03–1.25 (n=26), 1.23–2.09 (n=116), and 5.35–8.37 (n=72) mg/m2/day,
respectively. In conclusion, 1.2–2.1 mg/m2/day of PT values can be used as an
index of optimal control in CYP21A2 deficiency.
Collapse
Affiliation(s)
- Masako Izawa
- Department of Endocrinology and Metabolism, Tokyo Metropolitan Kiyose Children's Hospital, Tokyo, Japan
| | - Keiko Aso
- Department of Endocrinology and Metabolism, Tokyo Metropolitan Kiyose Children's Hospital, Tokyo, Japan
| | - Asako Higuchi
- Department of Endocrinology and Metabolism, Tokyo Metropolitan Kiyose Children's Hospital, Tokyo, Japan
| | - Daisuke Ariyasu
- Department of Endocrinology and Metabolism, Tokyo Metropolitan Kiyose Children's Hospital, Tokyo, Japan
| | - Yukihiro Hasegawa
- Department of Endocrinology and Metabolism, Tokyo Metropolitan Kiyose Children's Hospital, Tokyo, Japan
| |
Collapse
|
19
|
Numakura C, Yamada M, Ariyasu D, Maesaka A, Kobayashi H, Nishimura G, Ikeda M, Hasegawa Y. Genetic and enzymatic analysis for two Japanese patients with idiopathic infantile arterial calcification. J Bone Miner Metab 2006; 24:48-52. [PMID: 16369898 DOI: 10.1007/s00774-005-0645-0] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/16/2005] [Accepted: 07/15/2005] [Indexed: 11/26/2022]
Abstract
Idiopathic infantile arterial calcification (IIAC) is a life-threatening disorder in young infants. Cardiovascular symptoms are usually apparent within the first month of life. The symptoms are caused by calcification of large and medium-sized arteries, including the aorta, coronary arteries, and renal arteries. Most of the patients die by 6 months of age because of heart failure. Recently, homozygous or compound heterozygous mutations for the ectonucleotide pyrophosphatase/phosphodiesterase 1 (ENPP1) gene were reported as causative for the disorder. ENPP1 regulates extracellular inorganic pyrophosphate (PPi), a major inhibiter of extracellular matrix calcification. Two Japanese patients with IIAC were studied. One, from first-cousin parents, showed a typical clinical course. The onset in the second patient was late. Both of the patients were clinically compatible for IIAC; arterial calcification was shown, and hypertension was prominent. We sequenced all the exons and exon-intron boundaries of the gene and measured nucleotide pyrophosphohydrolase (NPPH) activity of ENPP1. Homozygous Arg730Stop was detected in the typical IIAC patient. The mutation was a novel nonsense mutation and not detected in 60 healthy controls. His NPPH activity was 4% of normal. On the other hand, the late-onset patient was not shown to have any mutations. NPPH activity in this patient was 70% of normal. We confirmed that ENPP1 was also responsible for the Japanese patient with IIAC. The atypical late-onset phenotype may not be associated with ENPP1 abnormalities. IIAC is considered to be a clinically and genetically heterogeneous disorder.
Collapse
Affiliation(s)
- Chikahiko Numakura
- Endocrinology and Metabolism Unit, Tokyo Metropolitan Kiyose Children's Hospital, Kiyose, Japan.
| | | | | | | | | | | | | | | |
Collapse
|
20
|
Shinjoh M, Miyairi I, Sakurai M, Takahashi M, Ariyasu D, Nakayama T, Tokumura M, Yamashita R, Sunakawa K, Takahashi T. Cryptococcal meningitis in an immunocompetent child. Eur J Pediatr 2005; 164:596-7. [PMID: 15959803 DOI: 10.1007/s00431-005-1708-x] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/24/2005] [Accepted: 04/29/2005] [Indexed: 10/25/2022]
Affiliation(s)
- Masayoshi Shinjoh
- Department of Pediatrics, School of Medicine, Keio University, 35 Shinanomachi, 160-8582 Shinjuku-ku, Tokyo, Japan.
| | | | | | | | | | | | | | | | | | | |
Collapse
|